Safety Assessment of Antimicrobial Agents: Criteria for the Balance Between Efficacy and Safety (Aventis Pharma/Daiichi Pharmaceutical Co. Ltd./ Ortho-McNeil Pharmaceutical Inc. Joint-Sponsored Symposium At the 22nd International Congress of Chemotherapy)
| Introduction | |
 |
|
| Criteria for the Choice of Antimicrobial Agent: Examining the Balance Between Efficacy, Safety, and Tolerability | |
 |
Professor Andy Hoepelman Head of Department of Acute Medicine and Infectious Diseases Professor of Department of Medicine University Medical Center Utrecht Utrecht, The Netherlands |
|
|
| Clinical Pharmacokinetic/Pharmacodynamic Evidence Regarding the Safety of Levofloxacin | |
 |
Professor William Craig Professor of Department of Medicine University of Wisconsin Madison, WI, USA |
|
|
| Comparison of Safety Profile of Levofloxacin and Other Agents (  -Lactams/-Lactamase Inhibitors, Macrolides, and Other Quinolones ) |
|
 |
Professor Javier Garau Head of Department of Medicine Hospital Mutua de Terrassa Associate Professor of Medicine University of Barcelona Barcelona, Spain |
|
|
| Drug-Drug Interactions with Levofloxacin: Tolerance and Contraindications | |
 |
Professor Enrico Mini Associate Professor of Chemotherapy Department of Preclinical and Clinical Pharmacology University of Florence Florence, Italy |
|
|
| Levofloxacin Safety Update Focusing on Cardiotoxicity | |
 |
Professor Ethan Rubinstein Professor of Department of Internal Medicine and Unit of Infectious Diseases Tel Aviv University School of Medicine, Tel Aviv, Israel |
|
|
| Summary | |
LATEST TOPICS
RELATED ARTICLES
